Business · 26/06/1995
FDA Proposes to Withdraw Approval of KV Pharmaceutical Co.'s Abbreviated Drug Applications
The FDA is proposing to withdraw approval of two abbreviated new drug applications and one abbreviated antibiotic drug application held by KV Pharmaceutical Co. due to untrue statements of material fact and insufficient evidence of the drugs' intended effects.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →